TY  - JOUR
A1  - Scognamiglio, Roberta
A1  - Cabezas-Wallscheid, Nina
A1  - Thier, Marc Christian
A1  - Altamura, Sandro
A1  - Reyes, Alejandro
A1  - Prendergast, Áine M.
A1  - Baumgärtner, Daniel
A1  - Carnevalli, Larissa S.
A1  - Atzberger, Ann
A1  - Haas, Simon
A1  - von Paleske, Lisa
A1  - Boroviak, Thorsten
A1  - Wörsdörfer, Philipp
A1  - Essers, Marieke A. G.
A1  - Kloz, Ulrich
A1  - Eisenman, Robert N.
A1  - Edenhofer, Frank
A1  - Bertone, Paul
A1  - Huber, Wolfgang
A1  - van der Hoeven, Franciscus
A1  - Smith, Austin
A1  - Trumpp, Andreas
T1  - Myc depletion induces a pluripotent dormant state mimicking diapause
JF  - Cell
N2  - Mouse embryonic stem cells (ESCs) are maintained in a naive ground state of pluripotency in the presence of MEK and GSK3 inhibitors. Here, we show that ground-state ESCs express low Myc levels. Deletion of both c-myc and N-myc (dKO) or pharmacological inhibition of Myc activity strongly decreases transcription, splicing, and protein synthesis, leading to proliferation arrest. This process is reversible and occurs without affecting pluripotency, suggesting that Myc-depleted stem cells enter a state of dormancy similar to embryonic diapause. Indeed, c-Myc is depleted in diapaused blastocysts, and the differential expression signatures of dKO ESCs and diapaused epiblasts are remarkably similar. Following Myc inhibition, pre-implantation blastocysts enter biosynthetic dormancy but can progress through their normal developmental program after transfer into pseudo-pregnant recipients. Our study shows that Myc controls the biosynthetic machinery of stem cells without affecting their potency, thus regulating their entry and exit from the dormant state.
KW  - hematopoietic stem cells
KW  - leukemia inhibitory factor
KW  - c-Myc
KW  - N-Myc
KW  - gene expression
KW  - embryonic stem cells
KW  - self-renewal
KW  - protein synthesis
Y1  - 2016
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-190868
VL  - 164
IS  - 4
ER  - 
TY  - JOUR
A1  - Schmitt, Jana
A1  - Keller, Andreas
A1  - Nourkami-Tutdibi, Nasenien
A1  - Heisel, Sabrina
A1  - Habel, Nunja
A1  - Leidinger, Petra
A1  - Ludwig, Nicole
A1  - Gessler, Manfred
A1  - Graf, Norbert
A1  - Berthold, Frank
A1  - Lenhof, Hans-Peter
A1  - Meese, Eckart
T1  - Autoantibody Signature Differentiates Wilms Tumor Patients from Neuroblastoma Patients
JF  - PLoS ONE
N2  - Several studies report autoantibody signatures in cancer. The majority of these studies analyzed adult tumors and compared the seroreactivity pattern of tumor patients with the pattern in healthy controls. Here, we compared the autoimmune response in patients with neuroblastoma and patients with Wilms tumor representing two different childhood tumors. We were able to differentiate untreated neuroblastoma patients from untreated Wilms tumor patients with an accuracy of 86.8%, a sensitivity of 87.0% and a specificity of 86.7%. The separation of treated neuroblastoma patients from treated Wilms tumor patients' yielded comparable results with an accuracy of 83.8%. We furthermore identified the antigens that contribute most to the differentiation between both tumor types. The analysis of these antigens revealed that neuroblastoma was considerably more immunogenic than Wilms tumor. The reported antigens have not been found to be relevant for comparative analyses between other tumors and controls. In summary, neuroblastoma appears as a highly immunogenic tumor as demonstrated by the extended number of antigens that separate this tumor from Wilms tumor.
KW  - Heparan-sulfate
KW  - N-Myc
KW  - Serum autoantibodies
KW  - Suppressors EXT1
KW  - Neuro-blastoma
KW  - Allelic loss
KW  - Lung-cancer
KW  - Children
KW  - Amplification
KW  - Therapy
Y1  - 2011
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-133794
VL  - 6
IS  - 12
ER  -